News
The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback